• The new campus combines R&D, manufacturing and training with the latest state-of-the-art facilities

  • Brings innovation to next-level integration with healthcare professionals

  • Expected to reach industrial scale production levels with production value above 10 billion RMB (approximately US$1.38 billion) in three to five years

SINGAPORE, November 13, 2022 /PRNewswire/ — Genesis MedTech Group (Genesis MedTech or Group) has officially unveiled its state-of-the-art medtech campus (Campus) in Wuxi, China. Representing the first major R&D and manufacturing facility of its kind in Chinait extends over 135,333 m² and has completed its first phase of development, comprising an innovation center (Innovation Center), and two R&D and production centers (R&D and Manufacturing Center).

The Innovation Center provides an open educational platform to foster deeper engagement and interaction between Genesis MedTech and healthcare professionals. It provides healthcare professionals with access to clinical training on the latest innovations in medical technology, covering multiple disease areas, such as minimally invasive surgery, vascular interventions and structural heart disease.

The Innovation Center’s training facilities provide the highest level of education and hands-on experience, recreating real clinical situations for healthcare professionals to understand and familiarize themselves with cutting-edge medical devices.

Recreate real clinical situations for healthcare professionals to understand and familiarize themselves with state-of-the-art medical devices.

The campus also houses the R&D and Manufacturing Center, which develops and manufactures high-quality medical devices, focusing on cutting-edge medtech devices for minimally invasive surgery and vascular procedures. Pilot production began in September 2022 and is expected to be mass-produced by 1H2023. It is expected to reach industrial scale production levels with a production value exceeding 10 billion RMB (approximately US$1.38 billion) in three to five years.

warren wangPresident and CEO of Genesis MedTech, said, “We are trying to play a vital role in MedTech innovation that will revolutionize the way medical technology development is intimately integrated with the practical needs of healthcare professionals. Through training and exchange, we can better understand clinical needs, drive technological innovation and expand product development. The Campus will be a state-of-the-art nexus for R&D, manufacturing, training and exchange, providing our R&D teams and global experts an open platform to explore innovations from scratch, becoming an exploration and production hub for new techniques and products.”


Genesis MedTech Group is a medical device company headquartered in Singapore. Founded by a group of professionals and entrepreneurs with MedTech experience globally and in Asia, the company’s product portfolio is focused on multi-therapy medical device products for emerging markets with sales and distribution through its established sales network. Genesis MedTech Group covers the entire industry value chain from research and development, production, quality management, supply chain, marketing and sales.

For more information, visit



See original content to download multimedia:

SOURCE Genesis MedTech


Comments are closed.